genomic profiling

Boston, Massachusetts, USA, May 21, 2026 Foundation Medicine has announced that the U.S. Food and Drug Administration (FDA) has...

CHICAGO — March 11, 2026 Tempus AI, Inc., a technology company focused on advancing precision medicine through artificial intelligence...